These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15761386)

  • 1. [Diagnostic and therapeutic opportunities in neuroendocrine tumors of the gastroenteropancreatic system].
    Bolanowski M; Kos-Kudła B
    Postepy Hig Med Dosw (Online); 2005; 59():48-55. PubMed ID: 15761386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnosis and medical management of advanced neuroendocrine tumors.
    Kaltsas GA; Besser GM; Grossman AB
    Endocr Rev; 2004 Jun; 25(3):458-511. PubMed ID: 15180952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system.
    Oberg K; Kvols L; Caplin M; Delle Fave G; de Herder W; Rindi G; Ruszniewski P; Woltering EA; Wiedenmann B
    Ann Oncol; 2004 Jun; 15(6):966-73. PubMed ID: 15151956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple effects of somatostatin analogs verified in three cases of metastasized neuroendocrine tumors of the gastroenteropancreatic system.
    Biliotti G; Martini F; Vaggelli L; Messerini L; Colagrande S; Pupi A; Seghi P
    Tumori; 2006; 92(2):170-4. PubMed ID: 16724698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition.
    Pobłocki J; Jasińska A; Syrenicz A; Andrysiak-Mamos E; Szczuko M
    Nutrients; 2020 May; 12(5):. PubMed ID: 32429294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroenteropancreatic neuroendocrine tumors: update on therapeutics.
    Ganetsky A; Bhatt V
    Ann Pharmacother; 2012 Jun; 46(6):851-62. PubMed ID: 22589450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostics and treatment of neuroendocrine tumors of the digestive tract in the light of the present standards].
    Szczeblowska D
    Pol Merkur Lekarski; 2007 May; 22(131):437-41. PubMed ID: 17679390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors.
    Turaga KK; Kvols LK
    CA Cancer J Clin; 2011; 61(2):113-32. PubMed ID: 21388967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemoembolization, immunotherapy and hormone therapy of carcinoid and digestive neuroendocrine tumors].
    Gouyon B; Ruszniewski P
    Ann Gastroenterol Hepatol (Paris); 1995; 31(2):121-3. PubMed ID: 7618834
    [No Abstract]   [Full Text] [Related]  

  • 10. Emerging therapeutic options for advanced enteropancreatic neuroendocrine tumors.
    Dasanu CA; Majumder S; Gopal S; Stoica-Mustafa E; Trikudanathan G
    Expert Opin Pharmacother; 2012 Mar; 13(4):461-71. PubMed ID: 22292707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin.
    Basu B; Sirohi B; Corrie P
    Endocr Relat Cancer; 2010 Mar; 17(1):R75-90. PubMed ID: 20008097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroendocrine tumors of the digestive system].
    Prónai L; Rácz K; Tulassay Z
    Orv Hetil; 2002 May; 143(19 Suppl):1081-6. PubMed ID: 12063866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin analogs for the treatment of neuroendocrine tumors.
    Culler MD; Oberg K; Arnold R; Krenning EP; Sevilla I; Díaz JA
    Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():9-17. PubMed ID: 21369878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gastrointestinal neuroendocrine tumors].
    Bornschein J; Kidd M; Malfertheiner P; Modlin IM
    Dtsch Med Wochenschr; 2008 Jul; 133(28-29):1505-10. PubMed ID: 18597210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Symptoms and diagnosis of neuroendocrine tumors of the digestive system].
    Gyökeres T
    Orv Hetil; 2011 Mar; 152(10):371-8. PubMed ID: 21354953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of non-functioning pancreatic islet cell tumors.
    Kouvaraki MA; Solorzano CC; Shapiro SE; Yao JC; Perrier ND; Lee JE; Evans DB
    J Surg Oncol; 2005 Mar; 89(3):170-85. PubMed ID: 15719379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
    Desai KK; Khan MS; Toumpanakis C; Caplin ME
    Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical Testing in Neuroendocrine Tumors.
    Aluri V; Dillon JS
    Endocrinol Metab Clin North Am; 2017 Sep; 46(3):669-677. PubMed ID: 28760232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
    Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
    Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues].
    Rubello D; Rufini V; De Carlo E; Martini C; Calcagni ML; Sicolo N; Troncone L; Casara D
    Minerva Endocrinol; 2003 Dec; 28(4):259-96. PubMed ID: 14752399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.